Having meaningful conversations with your dermatologist

Music track throughout.

Please see Indication and Safety Considerations within this video

DR. SEMINARA: To make the most out of their time with the doctor you really need to be an advocate for yourself. If you don’t feel like you’re getting the expectations that you want, I think it’s really important to tell them that because particularly with atopic dermatitis patients, they might be improved and that might be the best they’ve ever felt. But sometimes they need to kind of have even a higher aim.

MICHAEL R.: I appreciate what Dr. Seminara is saying because as the patient, I shouldn’t be satisfied. And that’s the point I had gotten to…I had just accepted this is the way life is. Because you can end up surrendering and going this is it, this is the best I'm going to get.

DR. SEMINARA: I think one of the most compelling things to doctors is giving specific examples.

For dermatologists, we’re very visual people. And so, even if the rash might look better, the itch can still be really considerable and the only person who can really talk about that is the patient, right? They're the one experiencing that.

MICHAEL R.: Have meaningful conversations with your doctor. You can’t get help unless you ask for it.

DR. SEMINARA: Let your doctor know that ‘yeah, I am better but I'm not as good as I want to be.’

RINVOQ USE

RINVOQ is a prescription medicine used to treat adults and children 12 years of age and older with moderate to severe eczema (atopic dermatitis) that did not respond to previous treatment and their eczema is not well controlled with other pills or injections, including biologic medicines, or the use of other pills or injections is not recommended. It is not known if RINVOQ is safe and effective in children under 12 years of age with atopic dermatitis.

Safety Considerations

RINVOQ (upadacitinib) may cause serious side effects, including:

  • Serious infections. RINVOQ can lower ability to fight infections. Serious infections, some fatal, occurred, including tuberculosis (TB) and infections caused by bacteria, fungi, or viruses.
  • Increased risk of death in people age 50+ with at least 1 heart disease risk factor.
  • Cancer and immune system problems. Increased risk of some cancers, including lymphoma and skin. Current or past smokers have higher risk for lymphoma and lung cancer.
  • Increased risk of major cardiovascular events such as heart attack, stroke, or death in people 50+ with at least 1 heart disease risk factor, especially in current or past smokers.
  • Blood clots, some fatal, in veins of the legs or lungs and arteries. This occurred more often in people 50+ with at least 1 heart disease risk factor.
  • Serious allergic reactions. Do not take if allergic to RINVOQ or its ingredients.
  • Tears in the stomach or intestines; changes in certain laboratory test results.

Please see additional Important Safety Information on the page below.